Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) EBITDA Margin (2012 - 2026)

Updated

Grace Therapeutics' EBITDA Margin came in at -11287.23% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 9773.51 percentage points from -1513.73% a year earlier and down 9107.52 percentage points from the prior quarter.

Analysis

Grace Therapeutics (GRCE) EBITDA Margin (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Grace Therapeutics reported EBITDA Margin of -3835.96%, down 1712.57 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -1616.06%, up 674.05 percentage points from FY2025.

  • EBITDA Margin carries a five-year change of +6289.55 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, EBITDA Margin was -2290.11% in FY2025 (-822.57 pp) and -1467.54% in FY2024.
  • The fiscal Q1 2027 figure represents the lowest quarterly EBITDA Margin since fiscal Q3 2016.
  • Year-over-year, EBITDA Margin increased in three of the last five quarters, with an average year-over-year change of -1390.17 percentage points.
  • Business Quant data shows GRCE's EBITDA Margin at -2179.71% (Q4 2026), -1422.09% (Q3 2026) and -1470.35% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 32.68%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 46.88%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 40.60%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 39.77%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 46.62%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 50.63%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 42.49%
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -1,487.66%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,287.23%
Mar 31, 2026 -2,179.71%
Dec 31, 2025 -1,422.09%
Sep 30, 2025 -1,470.35%
Jun 30, 2025 -1,513.73%
Mar 31, 2025 -1,728.80%
Dec 31, 2024 -2,914.96%
Sep 30, 2024 -2,653.30%
Jun 30, 2024 -2,111.49%
Mar 31, 2021 -1,999.13%
Dec 31, 2020 -2,424.69%
Mar 31, 2018 83.95%
Nov 30, 2016 -66.92%
Aug 31, 2016 -31,524.52%
May 31, 2016 -58,067.87%
Nov 30, 2015 -27,333.84%
Aug 31, 2015 -22,366.64%
May 31, 2015 -39,216.84%
Feb 28, 2015 -616.11%
Nov 30, 2014 -8,261.81%
API Access

Grace Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY